Cargando…
Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder
Bipolar disorder (BD) often progresses to a more chronic and treatment resistant (neuroprogressive) course. Identifying which patients are at risk could allow for early intervention and prevention. Bipolar disorder is highly comorbid with metabolic disorders including type II diabetes mellitus (T2DM...
Autores principales: | Calkin, Cynthia, McClelland, Christie, Cairns, Kathleen, Kamintsky, Lyna, Friedman, Alon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185298/ https://www.ncbi.nlm.nih.gov/pubmed/34113269 http://dx.doi.org/10.3389/fpsyt.2021.636174 |
Ejemplares similares
-
Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression
por: Kamintsky, Lyna, et al.
Publicado: (2019) -
Symptoms reported by Canadians posted in Havana are linked with reduced white matter fibre density
por: Aristi, Guillermo, et al.
Publicado: (2022) -
Virginia Woolf, neuroprogression, and bipolar disorder
por: Boeira, Manuela V., et al.
Publicado: (2016) -
Role of autoantibodies and blood–brain barrier leakage in cognitive impairment in systemic lupus erythematosus
por: Hanly, John G, et al.
Publicado: (2022) -
Cytokines in Bipolar Disorder: Paving the Way for Neuroprogression
por: Barbosa, Izabela Guimarães, et al.
Publicado: (2014)